• BioMedTech
  • Fintech
  • Contact
  • LinkedIn
  • YouTube

Truffle Capital News

The European Investment Bank supports CARMAT with € 30m for the marketing process of its total artificial heart

January 7, 2019

Download PDF
brand_carmat_png_.png

Carmat

Listed (EURONEXT) - First-of its kind implantable artificial heart

ALSO TO BE DISCOVERED

January 7, 2019

CARMAT announces the appointment of Pascale d’Arbonneau as Chief Financial Officer

October 26, 2018

Pharnext Announces Positive Topline Results from Pivotal Phase 3 Trial of PXT3003 for Treatment of Charcot-Marie-Tooth Type 1A Disease

October 26, 2018

Affluent medical announces significant clinical milestones with two of its innovative devices : Artus & Kalios

October 26, 2018

Affluent medical announces the successful conclusion of its optimise clinical study for kalios, the breakthrough mitral valve repair device

October 25, 2018

DEINOVE TO COLLABORATE WITH CALIBR TO EXPLORE BROADLY THE ANTI-INFECTIOUS POTENTIALS OF ITS BACTERIAL COLLECTION

October 10, 2018

Denis Gestin appointed as Chairman of Holistick Medical – first startup funded by Truffle Capital’s BioMedTech Crossover Fund

October 8, 2018

Truffle Capital announces exclusive and global License Agreement between Yale University and its newly created French start-up Nanosive

October 2, 2018

STRATEGIC PARTNERSHIP BETWEEN DEINOVE AND SOLVAY FOR THE MARKETING OF PHYTOENE IN NORTH AMERICA AND ASIA

September 20, 2018

Vincent Gardès, former CEO of VEXIM, joins Truffle Capital

September 4, 2018

Abivax reports impressive results in clinical phase 2a trial of ABX464 as an oral treatment for ulcerative colitis patients

62 Rue de Miromesnil, 75008 Paris, France

T. +33 1 82 28 46 00

E. contact@truffle.com

  • Truffle
  • Biomedtech
  • Fintech
  • Regulatory Information
  • ESG
  • Contact
  • Legal notices
  • LinkedIn
  • YouTube

Business Builders